← Eichor
Condition: Chinese Healthy Adult Subjects Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chinese Healthy Adult Subjects

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
Phase 1 · 1 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07301203Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and
Phase 1 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07232758A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Phase 1 · 1 location(s) · Luye Pharma Group Ltd. · NCT07230652A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects
Phase 1 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT06576401A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and
Phase 1 · 1 location(s) · AbbVie · NCT07570147A Study to Evaluate HB0034 in Healthy Chinese Adult Participants
Phase 1 · 1 location(s) · Shanghai Huaota Biopharmaceutical Co., Ltd. · NCT06716151Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
Phase 1 · 4 location(s) · Vigonvita Life Sciences · NCT06504290VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
Phase 1 · 2 location(s) · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · NCT07254481An Early-stage Clinical Trial to Evaluate the Safety, Absorption, and Disposition of YR001 Ointment Following Topical Ap
Phase 1 · 1 location(s) · Hangzhou Yirui Pharmaceutical Technology Co., Ltd · NCT07673458A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray
Phase 1 · 1 location(s) · VivaVision Biotech, Inc · NCT07259538A Study of DC6001 Tablet in Healthy Chinese Adult Subjects
Phase 1 · 1 location(s) · Heronova Pharmaceuticals · NCT07417566A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
Phase 1 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07331389
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.